Forecast written on rural road.jpegAs 2016 winds down, am I the only one who feels exhausted? 

Between pharma-bro inspired drug pricing madness, a political season that felt like a Bravo reality TV show, and Leicester City robbing my beloved Tottenham Hotspur of their first shot at a Premiere League championship in a very long time, I think John Oliver summed up this year best in this video.

This is our last live blog post of 2016 and normally I’d use the space to extensively recap our year at Advera.  But after the year we’ve all just endured, I really don’t want to spend too much more time even thinking about 2016.  So, here’s our very condensed recap – we added some key new team members, launched our Evidex platform, expanded the scope of our Clinical Evidence safety coverage, and picked up new clients in all of our market segments.  We capped the year off with our Evidex platform being designated an Innovative Technology solution by Vizient.  All-in-all, a pretty good year.

But what I’m really looking forward to is 2017.  The winds of change are blowing around issues of drug safety, signal management, and increased interest in technology solutions throughout healthcare.  And while there is also quite a bit of uncertainty around our new incoming administration and the changes they may bring to various departments and programs, I’m cautiously optimistic that those fears will die down after the inauguration.

Here at Advera, we have big plans for 2017.  We’re rolling out widely expanded coverage in our clinical evidence module (i.e., lots more clinical trials under coverage) and launching Evidex Alerts – a daily updating system on all things drug safety for our subscribers.  Look for more details on both of those efforts early in 2017.  We’re also looking forward to expanding the scope of our relationships with existing clients and continuing to add new clients to our platform.

But most of all, we’re looking forward to putting 2016 behind us!

From all of our team, we thank you for your interest in our endeavors and wish you a healthy and happy holiday season and New Year.

Topics: Drug Safety, Clinical Evidence, Evidex

Brian Overstreet

Written by Brian Overstreet